Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 71
Filtrar
1.
Arq. bras. oftalmol ; 82(1): 25-31, Jan.-Feb. 2019. tab
Artículo en Inglés | LILACS | ID: biblio-973871

RESUMEN

ABSTRACT Purpose: To compare effects of 5% topical povidone iodine with prophylactic topical azithromycin and moxifloxacin on bacterial flora in patients undergoing intravitreal injection. Methods: A total of 132 patients were randomly assigned to receive treatment with azithromycin or moxifloxacin, or no treatment (control group). In total, 528 specimens were obtained at the time of admission, 4 days before intravitreal injection, 4 days after intravitreal injection, and 8 days after intravitreal injection. Samples were immediately sent to the microbiology laboratory for incubation. Results: The microorganism observed most frequently was coagulasenegative Staphylococcus (23.8%). When the results of samples obtained on Day 4 before injection were assessed, growth of coagulase-negative Staphylococcus was significantly lower in the moxifloxacin group, compared with controls (p=0.049). Acinetobacter baumannii continued to grow after administration of azithromycin (p=0.033). When the results of four days after intravitreal injection were evaluated, growth of coagulase-ne gative Staphylococcus was higher in controls, compared with patients who received azithromycin or moxifloxacin (p=0.004). Eradication rate was significantly higher in the moxifloxacin group than in the control group (p=0.001). Samples obtained on Day 8 after intravitreal injection showed similar levels of bacterial growth in all groups (p=0.217). Conclusion: Moxifloxacin was more effective than 5% povidone iodine in controlling the growth of conjunctival bacterial flora. Use of moxifloxacin in combination with 5% povidone iodine resulted in a synergistic effect.


RESUMO Objetivo: Comparar os efeitos de iodopovidona tópico a 5% com azitromicina e moxifloxacina profiláticas sobre a flora bacteriana em pacientes submetidos à injeção intravítrea. Métodos: Um total de 132 pacientes foram aleatoriamente designados para receber tratamento com azitromicina ou moxifloxacina ou nenhum tratamento (grupo controle). No total, 528 amostras foram obtidas no momento na admissão, 4 dias antes da injeção intravítrea, 4 dias após a injeção intravítrea e 8 dias após a injeção intravítrea. As amostras foram imediatamente enviadas para o laboratório de microbiologia para incubação. Resultados: O microorganismo mais frequentemente observado foi o Staphylococcus coagulase-negativo (23,8%). Quando os resultados das amostras obtidas no dia 4 antes da injeção foram avaliados, o crescimento do Staphylococcus coagulase-negativo foi significativamente menor no grupo mo xifloxacina, em comparação com os controles (p=0,049). Acinetobacter baumannii continuou a crescer após a administração de azitromicina (p=0,033). Quando os resultados de 4 dias após a injeção intravítrea foram avaliados, o crescimento do Staphylococcus coagulase-negativo foi maior no controle, em comparação com pacientes que receberam azitromicina ou moxifloxacina (p=0,004). A taxa de erradicação também foi significativamente maior no grupo moxifloxacina do que no grupo controle (p=0,001). As amostras obtidas no dia 8 após injeção intravítrea mostraram níveis semelhantes de crescimento bacteriano em todos os grupos (p=0,217). Conclusão: A moxifloxacina foi mais eficaz do que 5% de iodopovidona no controle do crescimento da flora bacteriana conjuntival. O uso de moxifloxacina em combinação com 5% de iodopovidona resultou em um efeito sinérgico.


Asunto(s)
Humanos , Povidona Yodada/administración & dosificación , Azitromicina/administración & dosificación , Conjuntiva/microbiología , Inyecciones Intravítreas/métodos , Moxifloxacino/administración & dosificación , Antiinfecciosos Locales/administración & dosificación , Antibacterianos/administración & dosificación , Factores de Tiempo , Acinetobacter/aislamiento & purificación , Acinetobacter/efectos de los fármacos , Conjuntivitis Bacteriana/microbiología , Conjuntivitis Bacteriana/prevención & control , Endoftalmitis/microbiología , Endoftalmitis/prevención & control , Resultado del Tratamiento , Conjuntiva/efectos de los fármacos , Escherichia coli/aislamiento & purificación , Escherichia coli/efectos de los fármacos
2.
Mem. Inst. Oswaldo Cruz ; 114: e190020, 2019. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1012670

RESUMEN

BACKGROUND The multidrug resistance (MDR) phenotype is frequently observed in Acinetobacter baumannii, the most clinically relevant pathogenic species of its genus; recently, other species belonging to the A. calcoaceticus-A. baumannii complex have emerged as important MDR nosocomial pathogens. OBJECTIVES The present study aimed to verify the occurrence of metallo-β-lactamase genes among distinct Acinetobacter species in a hospital located in the Brazilian Amazon Region. METHODS Antimicrobial susceptibility profiles were determined by broth microdilution. The genetic relationships among these isolates were assessed by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). Pyrosequencing reads of plasmids carrying the bla NDM-1 gene were generated using the Ion Torrent™ platform sequencing. FINDINGS A total of six isolates carried bla NDM-1: A. baumannii (n = 2), A. nosocomialis (n = 3), and A. pittii (n = 1); three carried bla IMP-1: A. baumannii, A. nosocomialis, and A. bereziniae. Resistance to colistin was observed for an NDM-1-producing A. nosocomialis isolate. Diverse PFGE patterns and sequence types were found among A. nosocomialis and A. baumannii isolates. The bla NDM-1 sequence was inserted in a Tn125 transposon, while the bla IMP-1 was found as a gene cassette of the class 1 integron In86. MAIN CONCLUSIONS To the best of our knowledge, this is the first report describing the dissemination of bla NDM-1 among distinct Acinetobacter species recovered from the same hospital in South America.


Asunto(s)
Humanos , Compuestos Organometálicos , Acinetobacter/aislamiento & purificación , Acinetobacter/genética , beta-Lactamasas , Farmacorresistencia Microbiana/efectos de los fármacos , Infección Hospitalaria/transmisión , Unidades de Cuidados Intensivos
3.
Rev. Soc. Bras. Med. Trop ; 52: e20180348, 2019.
Artículo en Inglés | LILACS | ID: biblio-1013316

RESUMEN

Abstract We report the occurrence in Brazil of the bla NDM-1 gene in Acinetobacter pittii, prior to the previously described first reports regarding the species Providencia rettgeri and Enterobacter hormaechei. Clinical isolates were investigated by polymerase chain reaction followed by bidirectional sequencing, and species was confirmed by 16S rDNA sequencing and matrix-assisted laser desorption-ionization time-of-flight spectrometry. A. pittii carrying bla NDM-1 was confirmed in a patient with no national or international travel history, or transfer from another hospital. The findings warn of the possibility of silent spread of bla NDM-1 to the community.


Asunto(s)
Humanos , Femenino , Anciano de 80 o más Años , Acinetobacter/aislamiento & purificación , beta-Lactamasas/aislamiento & purificación , Infecciones por Acinetobacter/microbiología , Antibacterianos/uso terapéutico , beta-Lactamasas/genética , Brasil , Infecciones por Acinetobacter/tratamiento farmacológico , Pruebas de Sensibilidad Microbiana
4.
Braz. j. microbiol ; 48(2): 189-190, April.-June 2017. tab
Artículo en Inglés | LILACS | ID: biblio-839388

RESUMEN

Abstract We report here the draft genome sequence of Acinetobacter sp. Strain V2 isolated from the oil contaminated soil collected from ENGEN, Amanzimtoti, South Africa. Degradation of phenolic compounds such as phenol, toluene, aniline etc. at 400 ppm in 24 h and oil degrading capability makes this organism an efficient multifunctional bioremediator. Genome sequencing of Acinetobacter spp. V2 was carried out on Illumina HiSeq 2000 platform (performed by the Beijing Genomics Institute [BGI], Shenzhen, China). The data obtained revealed 643 contigs with genome size of 4.0 Mb and G + C content of 38.59%.


Asunto(s)
Acinetobacter/genética , Acinetobacter/metabolismo , ADN Bacteriano/genética , ADN Bacteriano/química , Aceites/metabolismo , Genoma Bacteriano , Análisis de Secuencia de ADN , Fenoles/metabolismo , Microbiología del Suelo , Contaminantes del Suelo/metabolismo , Sudáfrica , Composición de Base , Acinetobacter/aislamiento & purificación , Biotransformación
5.
Braz. j. microbiol ; 48(2): 196-197, April.-June 2017.
Artículo en Inglés | LILACS | ID: biblio-839366

RESUMEN

Abstract Worldwide increasing emergence of carbapenem-resistant Acinetobacter spp. has rendered the limited availability of effective antimicrobial agents and has become a major public health concern. In this study, we report the draft genome sequence of A. pittii TCM156, a multidrug-resistant isolate that harbored the blaOXA-357 gene. The genome sequence was further analyzed by various bioinformatics methods. The genome size was estimated to be 3,807,313 bp with 3508 predicted coding regions and G + C content is 38.7%. These findings have raised awareness of the possible emergence of OXA-type enzyme-producing A. pittii isolate in China.


Asunto(s)
Acinetobacter/genética , beta-Lactamasas/metabolismo , Infecciones por Acinetobacter/microbiología , ADN Bacteriano/química , Genoma Bacteriano , Análisis de Secuencia de ADN , Farmacorresistencia Bacteriana Múltiple , Composición de Base , Acinetobacter/aislamiento & purificación , Acinetobacter/efectos de los fármacos , Acinetobacter/enzimología , ADN Bacteriano/genética , China
6.
Braz. j. infect. dis ; 21(1): 98-101, Jan.-Feb. 2017. tab
Artículo en Inglés | LILACS | ID: biblio-1039180

RESUMEN

Abstract Colistin resistance involving Gram-negative bacilli infections is a challenge for health institutions around of the world. Carbapenem-resistance among these isolates makes colistin the last therapeutic option for this treatment. Colistin resistance among Enterobacteriaceae, Acinetobacter spp., and Pseudomonas spp. was evaluated between 2010 and 2014 years, at Hospital das Clínicas, São Paulo, Brazil. Over five years 1346 (4.0%) colistin resistant Gram-negative bacilli were evaluated. Enterobacteriaceae was the most frequent (86.1%) pathogen isolated, followed by Acinetobacter spp. (7.6%), and Pseudomonas spp. (6.3%). By temporal analysis there was a trend for an increase of colistin resistance among Enterobacteriaceae, but not among non-fermentative isolates. Among 1346 colistin resistant isolates, carbapenem susceptibility was observed in 21.5%. Colistin resistance in our hospital has been alarmingly increased among Klebsiella pneumoniae isolates in both KPC positive and negative, thus becoming a therapeutic problem.


Asunto(s)
Humanos , Pseudomonas/efectos de los fármacos , Acinetobacter/efectos de los fármacos , Colistina/farmacología , Farmacorresistencia Bacteriana/efectos de los fármacos , Enterobacteriaceae/efectos de los fármacos , Antibacterianos/farmacología , Pseudomonas/aislamiento & purificación , Factores de Tiempo , Acinetobacter/aislamiento & purificación , Brasil , Pruebas de Sensibilidad Microbiana , Estudios Retrospectivos , Enterobacteriaceae/aislamiento & purificación , Hospitales Universitarios
7.
Braz. j. microbiol ; 46(2): 367-375, Apr-Jun/2015. tab, graf
Artículo en Inglés | LILACS | ID: lil-749711

RESUMEN

The pH of the culture medium directly influences the growth of microorganisms and the chemical processes that they perform. The aim of this study was to assess the influence of the initial pH of the culture medium on the production of 11 low-molecular-weight organic acids and on the solubilization of calcium phosphate by bacteria in growth medium (NBRIP). The following strains isolated from cowpea nodules were studied: UFLA03-08 (Rhizobium tropici), UFLA03-09 (Acinetobacter sp.), UFLA03-10 (Paenibacillus kribbensis), UFLA03-106 (Paenibacillus kribbensis) and UFLA03-116 (Paenibacillus sp.). The strains UFLA03-08, UFLA03-09, UFLA03-10 and UFLA03-106 solubilized Ca3(PO4)2 in liquid medium regardless of the initial pH, although without a significant difference between the treatments. The production of organic acids by these strains was assessed for all of the initial pH values investigated, and differences between the treatments were observed. Strains UFLA03-09 and UFLA03-10 produced the same acids at different initial pH values in the culture medium. There was no correlation between phosphorus solubilized from Ca3(PO4)2 in NBRIP liquid medium and the concentration of total organic acids at the different initial pH values. Therefore, the initial pH of the culture medium influences the production of organic acids by the strains UFLA03-08, UFLA03-09, UFLA03-10 and UFLA03-106 but it does not affect calcium phosphate solubilization.


Asunto(s)
Acinetobacter/metabolismo , Ácidos Carboxílicos/metabolismo , Medios de Cultivo/química , Paenibacillus/metabolismo , Fosfatos/metabolismo , Rhizobium tropici/metabolismo , Acinetobacter/crecimiento & desarrollo , Acinetobacter/aislamiento & purificación , Fabaceae/microbiología , Concentración de Iones de Hidrógeno , Paenibacillus/crecimiento & desarrollo , Paenibacillus/aislamiento & purificación , Rhizobium tropici/crecimiento & desarrollo , Rhizobium tropici/aislamiento & purificación , Nódulos de las Raíces de las Plantas/microbiología
8.
Rev. cuba. med. trop ; 66(3): 400-414, sep.-dic. 2014.
Artículo en Español | LILACS, CUMED | ID: lil-737009

RESUMEN

Introducción: Klebsiella pneumoniae y el complejo Acinetobacter baumannii-calcoaceticus constituyen importantes patógenos nosocomiales a nivel mundial siendo más susceptibles los pacientes ingresados en neonatología y unidades de cuidados intensivos. Objetivos: caracterizar, desde el punto de vista clínico-microbiológico los aislamientos de los géneros Klebsiella y Acinetobacter causantes de infecciones en hospitales pediátricos cubanos. Métodos: se realizó un estudio descriptivo-longitudinal durante el período de Junio 2011-Septiembre 2012 que incluyó 152 aislamientos clínicos (102 de Klebsiella spp. y 50 de Acinetobacter spp) causantes de infecciones nosocomiales en niños y que fueron remitidos al Laboratorio Nacional de Referencia de Microbiología del Instituto Pedro Kourí. La identificación de esta especie se realizó mediante pruebas bioquímicas. Se determinó la susceptibilidad a 18 antimicrobianos, la producción de ß;-lactamasas de espectro extendido (BLEE) y la de metalo-ß;-lactamasas (MBLs) según las normas del Instituto de Estandarización de Laboratorio Clínico (CLSI, por sus siglas en inglés). Resultados: las muestras más frecuentes de recuperación de Acinetobacter y Klebsiella fueron sangre, secreción endotraqueal y lesiones de piel. Klebsiella pneumoniae (96 por ciento) y el complejo Acinetobacter baumannii-calcoaceticus (90 por ciento) fueron las especies más prevalentes y se aislaron con mayor frecuencia en servicios de terapias, neonatología y quemado. Ambos patógenos mostraron elevada resistencia a las cefalosporinas con 57 por ciento de producción de BLEE para el género Klebsiella spp. La resistencia a carbapenémicos solo se detectó en Acinetobacter spp (61 por ciento) mediada por la producción de metalo-&-lactamasas en un 2 por ciento de los aislamientos. La mayor susceptibilidad de este género se encontró para las tetraciclinas, mientras que el género Klebsiella spp. fue más susceptible a la ciprofloxacina. En ambos se observó resistencia elevada para los aminoglucósidos (66 por ciento-75 por ciento) y el trimetoprim-sulfametoxazol (45 por ciento-60 por ciento). Conclusiones: Klebsiella pneumoniae y el Complejo Acinetobacter baumannii-calcoaceticus constituyen un peligro potencial en servicios pediátricos con escasas opciones terapéuticas quedando como únicas alternativas los carbapenémicos para las infecciones por Klebsiella spp multidrogorresistentes y la colistina para las infecciones por Acinetobacter spp con extrema drogorresistencia(AU)


Introduction: Klebsiella pneumoniae and the Acinetobacter baumannii-calcoaceticus complex represent important nosocomial pathogens worldwide. The patients admitted to the neonatology and the intensive care unit services suffer infections very frequently. Objectives: to characterize clinically and microbiologically Klebsiella and Acinetobacter isolates causing infections in Cuban pediatric hospitals. Methods: a descriptive longitudinal study of 152 clinical isolates (102 Klebsiella spp and 50 Acinetobacter spp), which caused nosocomial infections in children and were sent to the national reference laboratory of microbiology in Pedro Kouri Institute. The study was conducted from June 2011 to September 2012. The species were identified by biochemical tests. The susceptibility to 18 antimicrobials, the production of extended spectrum ß-lactamase (ESBL) and metallo-ß-lactamases were determined according to the Clinical and Laboratory Standards Institute. Results: the most frequent infections in infants and children by Acinetobacter and Klebsiella were found in blood, endotracheal secretion and skin lesions.. Klebsiella pneumoniae (96 percent) and Acinetobacter baumannii-calcoaceticus complexes (90 percent) were the most prevalent species and were frequently isolated in intensive care, neonatology and burned patient wards. Both pathogens showed high resistance to cephalosporins with 57 percent of extended-spectrum betalactamase production in Klebsiella spp. Resistance to carbapenems was only detected in Acinetobacter (61 percent) with 2 percent of metallobetalactamse production. Acinetobacter spp. was more susceptible to tetracyclines and cholistin where Klebsiella spp was more susceptible to ciprofloxacin. In both pathogens, a high resistance to aminoglycosides (66 percent -75 percent) and trimethoprim-sulfamethoxazole (45 percent-60 percent) was observed. Conclusions: Klebsiella pneumoniae and Acinetobacter baumannii-calcoaceticus complex represent a potential threat in pediatric services with few therapeutic options. The carbapenems remain the only alternative to severe infections caused by multidrug resistant Klebsiella spp and cholistin is the only choice to treat extreme multidrug resistant Acinetobacter spp infections(AU)


Asunto(s)
Humanos , Masculino , Femenino , Recién Nacido , Lactante , Acinetobacter/aislamiento & purificación , Farmacorresistencia Microbiana/efectos de los fármacos , Infección Hospitalaria/prevención & control , Prueba de Laboratorio/métodos , Klebsiella pneumoniae/aislamiento & purificación , Epidemiología Descriptiva , Estudios Longitudinales
9.
Rev. cuba. med. trop ; 66(3): 386-399, sep.-dic. 2014.
Artículo en Español | LILACS, CUMED | ID: lil-737008

RESUMEN

Introducción: el género Klebsiella causa brotes hospitalarios, por cepas multidrogorresistentes en diferentes continentes y conlleva a un aumento en la morbimortalidad. Objetivos: identificar las especies de Klebsiella causantes de infecciones en hospitales cubanos, determinar la procedencia de los aislamientos según el servicio, y la susceptibilidad antimicrobiana, conocer la prevalencia de aislamientos productores de ß-lactamasas de espectro extendido (BLEE), y tipos, así como la susceptibilidad de los mismos a diferentes antimicrobianos de interés terapéutico. Métodos: se realizó un estudio descriptivo en 448 aislamientos de Klebsiella spp. recibidos en el Laboratorio Nacional de Referencia de Microbiología del IPK (LRNM/IPK) procedentes de 40 hospitales de 12 provincias del país durante el período de 2010 a 2012. La identificación de las especies se realizó mediante pruebas bioquímicas convencionales y por la técnica de Espectrometría de masas MS MALDI-TOF. Se determinó la susceptibilidad a 15 antimicrobianos mediante el método E-test y la producción de BLEE mediante el método de discos combinados según las recomendaciones del Instituto de Estándares Clínicos y de Laboratorio. Los genes blaESBL se determinaron mediante la reacción en cadena de la polimerasa según protocolo descrito previamente. Resultados: la especie prevalente fue Klebsiella pneumoniae (95,1 %), seguida por K. oxytoca (4,5 %) y K. ozaenae (0,4 %). Los aislamientos procedieron, principalmente, de los servicios de Unidades de Cuidados Intensivos (26,3 %), cirugía (22 %) y neonatología (13 %). La mayor resistencia se observó para las cefalosporinas (48-52 %), trimetoprim-sulfametoxazol (49 %), gentamicina (43 %), ácido nalidíxico (38 %) y tetraciclina (34 %). El 52 % de los aislamientos fueron productores de BLEE y prevaleció la enzima CTX-M (82 %) y la TEM (70 %). Conclusiones: se evidencia la repercusión clínica de Klebsiella spp. en hospitales cubanos con elevada resistencia a diferentes antimicrobianos. La producción de BLEE es un mecanismo de resistencia importante en esta bacteria en las que los carbapenémicos, la piperacilina-tazobactam, la colistina, y la tigeciclina juegan un rol terapéutico importante.


Introduction: the Klebsiella genus gives rise to many hospital outbreaks due to multi-drug-resistant strains on different continents and leads to increased morbidity and mortality. Objectives: to identify the Klebsiella species causing infections in Cuban hospitals, to determine the origin of isolates per service, their antimicrobial susceptibility and, to determine the production and type of extended-spectrum ß-lactamases (ESBLs) and the susceptibility of these isolations to several antimicrobials of therapeutic interest. Methods: a descriptive study was conducted on 448 Klebsiella spp. Isolates that were received in the national reference microbiology laboratory of "Pedro Kouri" Institute of Tropical Medicine from 40 hospitals located in 12 Cuban provinces during the 2010-2012 period. Species identification was based on conventional biochemical tests and mass spectrometry technique called MS MALDI-TOF. The susceptibility to 15 antimicrobials and the extended spectrum ß-lactamase production were determined by the E-test method and by the combined disks method, respectively, according to recommendations of the Institute of Clinical and Laboratory Standards. The polymerase chain reaction made it possible the detection of BlaESBL genes as indicated in the previously described protocol. Results: Klebsiella pneumoniae (95.4 %) was the prevalent species, followed by K. oxytoca (4.1%), and K. ozaenae (0.5 %). The isolates were mainly from the intensive care units (26.3 %), surgery (22 %), and neonatology (13%) services. The highest resistance rate was observed for cephalosporins (48-52 %), trimethoprim-sulfamethoxazole (49 %), gentamicin (43 %), nalidixic acid (38 %), and tetracycline (34 %). Fifty-two percent of the isolates were extended spectrum ß-lactamase producers, with CTX-M (82 %) and TEM (70 %) enzymes prevailing. Conclusions: This study shows the clinical impact of Klebsiella spp in Cuban hospitals, which is highly resistant to different antimicrobials. The production of extended spectrum ß-lactamases provides a significant resistance mechanism in Klebsiella in which carbapenems, piperacillin-tazobactam, cholistin and tigecycline play an important therapeutic role.


Asunto(s)
Humanos , Recién Nacido , Lactante , Acinetobacter/aislamiento & purificación , Farmacorresistencia Bacteriana/efectos de los fármacos , Klebsiella pneumoniae/aislamiento & purificación , Infección Hospitalaria/prevención & control , Epidemiología Descriptiva , Cuba
10.
Braz. j. microbiol ; 45(2): 495-501, Apr.-June 2014. graf, tab
Artículo en Inglés | LILACS | ID: lil-723105

RESUMEN

P. aeruginosa and Acinetobacter spp. are important pathogens associated with late nosocomial pneumonia in hospitalized and institutionalized individuals. The oral cavity may be a major source of these respiratory pathogens, particularly in the presence of poor oral hygiene and periodontal infection. This study investigated the prevalence of P. aeruginosa and Acinetobacter spp. in subgingival biofilm and saliva of subjects with periodontal disease or health. Samples were obtained from 55 periodontally healthy (PH) and 169 chronic periodontitis (CP) patients. DNA was obtained from the samples and detection of P. aeruginosa and Acinetobacter spp. was carried out by multiplex and nested PCR. P. aeruginosa and Acinetobacter spp. were detected in 40% and 45% of all samples, respectively. No significant differences in the distribution of these microorganisms between men and women, subgingival biofilm and saliva samples, patients < 35 and > 35 years of age, and smokers and non-smokers were observed regardless periodontal status (p > 0.05). In contrast, the frequencies of P. aeruginosa and Acinetobacter spp. in saliva and biofilm samples were significantly greater in CP than PH patients (p < 0.01). Smokers presenting P. aeruginosa and high frequencies of supragingival plaque were more likely to present CP than PH. P. aeruginosa and Acinetobacter spp. are frequently detected in the oral microbiota of CP. Poor oral hygiene, smoking and the presence of P. aeruginosa are strongly associated with periodontitis.


Asunto(s)
Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Adulto Joven , Acinetobacter/aislamiento & purificación , Biopelículas/crecimiento & desarrollo , Encía/microbiología , Voluntarios Sanos , Enfermedades Periodontales/microbiología , Pseudomonas aeruginosa/aislamiento & purificación , Saliva/microbiología , Acinetobacter/fisiología , ADN Bacteriano/genética , ADN Bacteriano/aislamiento & purificación , Reacción en Cadena de la Polimerasa , Prevalencia , Pseudomonas aeruginosa/fisiología
11.
Artículo en Inglés | IMSEAR | ID: sea-157562

RESUMEN

Bacteria of genus acinetobacter, invariably susceptible to many antibiotics earlier have emerged as a multidrug resistant opportunistic pathogen in recent years. Unwarranted and unrestricted usage of an antibiotic is associated with drug resistance in thereat in infections by acinetobacter species. Rapid detection of Metallo – Betalactamase starins can be done to prevent their dissemtination. The present study is undertaken to know antibiotic sensitivity pattern of acinetobacter species and screen the imipenem resistant starins for Metallo Beta Lactamase (MBL) production by various phenotypic methods.


Asunto(s)
Acinetobacter/tratamiento farmacológico , Acinetobacter/genética , Acinetobacter/aislamiento & purificación , Carbapenémicos/farmacología , Farmacorresistencia Bacteriana Múltiple , Pruebas de Sensibilidad Microbiana , beta-Lactamasas/análisis
12.
Medical Sciences Journal of Islamic Azad University. 2013; 23 (2): 127-133
en Persa | IMEMR | ID: emr-130390

RESUMEN

The emergence of antimicrobial-resistant genes and the indiscriminate use of antibiotics contribute to the dissemination of resistant pathogens in the environment. The objective of the present study was isolation and molecular identification of antibiotic resistant bacteria from the hospital sewage and investigation of the role of plasmid in resistance mechanism. In this experimental study, the antibiotic resistance patterns of the isolated strains from hospital effluent samples were assayed by disc diffusion method. The selected isolate was identified by morphological and biochemical methods in accordance with Bergey's Manual of Systematic Bacteriology. Phylogenetic analysis was performed based on 16S rRNA gene sequences. Plasmid extraction was carried out by alkaline lysis technique and curing of plasmids performed by Ethidium bromide. Ten bacterial strains were isolated from hospital sewage. Results of antibiotic susceptibility test showed that all of the isolates were multi-drug resistant. One of the isolates [ST1] was resistant to all of the tested antibiotics. Phylogenetic analysis based on 16S rRNA gene sequences indicated that the isolate belongs to the genus Acinetobacter then designated as Acinetobacter sp. HM_C. Phylogenetically the closest relative of strain was Acinetobacter baumanni IARI-V-4. Curing experiments by Ethidium bromide caused the elimination of all plasmids. The sensitivity of the plasmid cured ST1 to gentamycin, and amikacin indicated that the genes encoding resistance to gentamycin, and amikacin were located on plasmid. Hospital effluents are important materials in dissemination of multidrug resistant bacteria and their resistant genes into the environment


Asunto(s)
Farmacorresistencia Microbiana , Plásmidos , Aguas del Alcantarillado , Hospitales , Acinetobacter/aislamiento & purificación
13.
Braz. j. infect. dis ; 16(6): 521-526, Nov.-Dec. 2012. ilus, tab
Artículo en Inglés | LILACS | ID: lil-658921

RESUMEN

INTRODUCTION: Acinetobacter spp. have emerged as notorious pathogens involved in healthcareassociated infections. Carbapenems are important antimicrobial agents for treating infections due to multidrug resistant Acinetobacter spp. Different mechanisms may confer resistance to these drugs in the genus, particularly production of class D carbapenemases. OXA-23-like family has been pointed out as one of the predominant carbapenamases among Acinetobacter. The present work aimed to investigate the occurrence of OXA-23-like carbapenemases among Acinetobacter isolates recovered from patients of a university hospital in Niterói, RJ, Brazil. METHODS: Antimicrobial susceptibility profiles were determined by disk-diffusion. Imipenem resistant isolates were submitted to Modified Hodge Test in order to screen for carbapenemase production, and later to polymerase chain reaction (PCR) to investigate the presence of blaOXA-23. RESULTS: Imipenem and meropenem resistance rates were 71.4% and 69.7%, respectively. The Modified Hodge Test revealed carbapenemase production among 76 (89.4%) of the 85 imipenem resistant isolates analyzed; according to PCR results, 81 isolates (95.4%) carried the blaOXA-23 gene. CONCLUSIONS: OXA-23-like enzymes may be an important mechanism of carbapenem resistance among isolates present in the hospital studied.


Asunto(s)
Humanos , Acinetobacter/enzimología , beta-Lactamasas/análisis , Acinetobacter/efectos de los fármacos , Acinetobacter/aislamiento & purificación , Antibacterianos/farmacología , Brasil , Pruebas Antimicrobianas de Difusión por Disco , Farmacorresistencia Bacteriana , Hospitales Universitarios , Pruebas de Sensibilidad Microbiana , Reacción en Cadena de la Polimerasa , beta-Lactamasas/genética
14.
Indian J Pathol Microbiol ; 2012 Jul-Sept 55(3): 352-356
Artículo en Inglés | IMSEAR | ID: sea-142266

RESUMEN

Background: Nosocomial infection caused by non-Enterobacteriaceae gram negative bacteria (GNB-NE) is increasing in intensive care units (ICU). Aim: The objective of this study was to determine whether potable water in ICU wards at Tehran hospitals is contaminated with L. pneomophila, P. aeroginosa and Acinetobacter spp. Materials and Methods: A total of 52 water samples from shower bath and taps water in seven hospitals of Tehran were collected. The water sample concentrated by filtering through millipore cellulose filters and cultured on BCYE agar and tryptic soya agar media. The presence of Legionella pneumophila was confirmed by real time PCR assay using primers-probe designed for the mip gene. Results: Legionella pneumophila, Pseudomonas aeroginosa and Acinetobacter were isolated from 5 (9.6%), 6 (11.4%) and 1 (1.8%) of the hospital water systems, respectively. This study demonstrated the presence of Legionella, Pseudomonas and Acinetobacter in water system in ICU wards of different hospitals in Tehran. Conclusions: Hot water from shower heads could be a potential source of infection for Legionella pneumophila. Water was also proved to contain Pseudomonas aeruginonsa, the main GNB-NE causing nosocomila pneumonia at Tehran hospitals. Care should be taken concerning cleanliness and decontamination of water supplies at ICUs for pathogenic organisms.


Asunto(s)
Acinetobacter/aislamiento & purificación , Técnicas Bacteriológicas , Agua Potable/microbiología , Hospitales , Humanos , Unidades de Cuidados Intensivos , Irán , Legionella pneumophila/aislamiento & purificación , Reacción en Cadena de la Polimerasa , Pseudomonas aeruginosa/aislamiento & purificación , Abastecimiento de Agua
15.
Biomédica (Bogotá) ; 32(2): 179-181, abr.-jun. 2012. ilus
Artículo en Inglés | LILACS | ID: lil-656825

RESUMEN

Acinetobacter skin and soft tissue infection outside of the traumatic wound setting are rare occurrences. The majority of cases occur in the presence of significant comorbilities and by Acinetobacter baumanii. Herein a case is reported of community-onset, health-care-associated, non-traumatic cellulitis caused by Acinetobacter, species junii-johnsonii with bacteremia. This is the first reported case of Acinetobacter junii-johnsonii skin and soft tissue infection. Hemorrhagic bullae might be one of the clinical features of Acinetobacter cellulitis.


La infección de piel y tejidos blandos por Acinetobacter no relacionada con trauma es una presentación inusual. La mayoría de los casos descritos presentan enfermedades concomitantes y son causados por Acinetobacter baumanii. Se describe un caso de celulitis no traumática por A. junii-johnsonii con bacteriemia, de inicio en la comunidad y asociado con el tratamiento médico. De acuerdo con nuestro conocimiento, éste sería el primer caso reportado de infección de tejidos blandos y piel por A. junii-johnsonii. La vesícula hemorrágica podría ser una característica clínica de celulitis por Acinetobacter.


Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Infecciones por Acinetobacter/microbiología , Acinetobacter/aislamiento & purificación , Celulitis (Flemón)/microbiología , Infecciones Oportunistas/microbiología , Infecciones por Acinetobacter/complicaciones , Infecciones por Acinetobacter/diagnóstico , Infecciones por Acinetobacter/tratamiento farmacológico , Adenocarcinoma/complicaciones , Adenocarcinoma/tratamiento farmacológico , Adenocarcinoma/radioterapia , Antibacterianos/uso terapéutico , Bacteriemia/complicaciones , Bacteriemia/tratamiento farmacológico , Bacteriemia/microbiología , Coinfección , Celulitis (Flemón)/complicaciones , Celulitis (Flemón)/diagnóstico , Celulitis (Flemón)/tratamiento farmacológico , Infecciones Comunitarias Adquiridas/complicaciones , Infecciones Comunitarias Adquiridas/diagnóstico , Infecciones Comunitarias Adquiridas/tratamiento farmacológico , Infecciones Comunitarias Adquiridas/microbiología , Quimioterapia Combinada , Staphylococcus aureus Resistente a Meticilina/aislamiento & purificación , Infecciones Oportunistas/complicaciones , Infecciones Oportunistas/diagnóstico , Infecciones Oportunistas/tratamiento farmacológico , Neoplasias de la Próstata/complicaciones , Neoplasias de la Próstata/tratamiento farmacológico , Neoplasias de la Próstata/radioterapia , Infecciones por Serratia/complicaciones , Infecciones por Serratia/tratamiento farmacológico , Infecciones por Serratia/microbiología , Serratia marcescens/aislamiento & purificación , Choque Séptico/etiología , Choque Séptico/terapia , Traumatismos de la Médula Espinal/complicaciones , Fracturas de la Columna Vertebral/complicaciones , Infecciones Estafilocócicas/complicaciones , Vértebras Torácicas/lesiones , Infecciones Urinarias/complicaciones , Infecciones Urinarias/tratamiento farmacológico , Infecciones Urinarias/microbiología
17.
Bulletin of Pharmaceutical Sciences-Assiut University. 2012; 35 (Part 2): 99-107
en Inglés | IMEMR | ID: emr-160077

RESUMEN

This study aimed to isolation of Acinetobacter spp, detect resistance patterns of isolated strains, phenotypic and genotypic detection of Metallo-beta-lactamase and typing of isolated strains from clinical and environmental respectively. this study includes 440 different clinical specimens, 672 environmental samples, inoculated on different culture media, confirmation of isolates by API20NE, PCR to detect 16SrRNA-23SrRNA gene, determine susceptibility pattern of isolates to different antibiotics and phenotypic and Genotypic detection of bla -OXA 51-like gene. 24 strains of Acinetobacter [5.45%] were isolated from 440 clinical samples, 27 strains of Acinetobacter were isolated from 672 environmental samples [4.017%]. Tetracycline was the most active drug against multi-drug resistant A.baumannii. [48/51 or 94%] of Acinetobacter isolates showed increase in zone of inhibition around IPM/EDTA disc compared with IPM disc alone. [49/51 or 96%] of Acinetobacter isolates were detected by presence of 16srRNA - 23 srRNA gene [universal gene present in all Acinetobacter species]. [49/51 or 96%] of isolated Acinetobacter spp showed band with blaOXA-51-like" genes. [37/51 or 72.5%] Acinetobacter isolates showed positive bands for class I integrase gene [gene responsible for multi drug resistance and outbreaks in hospitals]


Asunto(s)
Acinetobacter/aislamiento & purificación , beta-Lactamasas , Hospitales Universitarios
18.
Rev. Soc. Bras. Med. Trop ; 44(6): 725-730, Nov.-Dec. 2011. graf, tab
Artículo en Inglés | LILACS | ID: lil-611754

RESUMEN

INTRODUCTION: Hospitals around the world have presented multiresistant Acinetobacter sp. outbreaks. The spread of these isolates that harbor an increasing variety of resistance genes makes the treatment of these infections and their control within the hospital environment more difficult. This study aimed to evaluate the occurrence and dissemination of Acinetobacter sp. multiresistant isolates and to identify acquired resistance genes. METHODS: We analyzed 274 clinical isolates of Acinetobacter sp. from five hospitals in Porto Alegre, RS, Brazil. We evaluated the susceptibility to antimicrobial, acquired resistance genes from Ambler's classes B and D, and performed molecular typing of the isolates using enterobacterial repetitive intergenic consensus-polymerase chain reaction (ERIC-PCR) technique. RESULTS: A high (68 percent) percentage of multiresistant isolates of Acinetobacter sp. was observed, and 69 percent were resistant to carbapenems. We identified 84 percent of isolates belonging to species A. baumannii because they presented the gene blaOXA-51. The gene blaOXA-23 was detected in 62 percent of the isolates, and among these, 98 percent were resistant to carbapenems. Using the ERIC-PCR technique, we identified clones of Acinetobacter sp. spread among the four hospitals analyzed during the sampling period. CONCLUSIONS: The data indicate the dissemination of Acinetobacter sp. isolates among hospitals and their permanence in the hospital after one year.


INTRODUÇÃO: Hospitais no mundo todo têm apresentado surtos de Acinetobacter sp. multirresistentes. A disseminação destes isolados com uma variedade cada vez maior de genes de resistência torna difícil o tratamento destas infecções e seu controle dentro do ambiente hospitalar. Este trabalho teve como objetivo avaliar a ocorrência e disseminação de isolados de Acinetobacter sp. multirresistentes e identificar genes de resistência adquirida. MÉTODOS: Foram avaliados 274 isolados clínicos de Acinetobacter sp. obtidos de cinco hospitais da Cidade de Porto Alegre, RS, Brasil. Avaliamos o perfil de suscetibilidade a antimicrobianos, genes de resistência adquirida das classes B e D de Ambler e realizamos a tipificação molecular dos isolados utilizando a técnica de enterobacterial repetitive intergenic consensus-polymerase chain reaction (ERIC-PCR). RESULTADOS: Encontramos uma alta (68 por cento) porcentagem de isolados de Acinetobacter sp. multirresistentes e 69 por cento dos isolados apresentaram resistência aos carbapenêmicos. Foram identificados 84 por cento de isolados pertencentes a espécie A. baumannii, pois apresentaram o gene blaOXA-51. Em 62 por cento dos isolados, foi detectado o gene blaOXA-23, sendo que 98 por cento destes isolados foram resistentes aos carbapenêmicos. Através da tipificação molecular pela técnica de ERIC-PCR identificamos clones de Acinetobacter sp. disseminados entre quatro dos hospitais analisados e nos anos de 2006 e 2007. CONCLUSÕES: Os dados obtidos indicam a disseminação de isolados de Acinetobacter sp. entre hospitais assim como sua permanência no ambiente hospitalar após um ano.


Asunto(s)
Humanos , Acinetobacter/efectos de los fármacos , Antibacterianos/farmacología , Farmacorresistencia Bacteriana Múltiple/genética , Genes Bacterianos/genética , Acinetobacter/genética , Acinetobacter/aislamiento & purificación , Técnicas de Tipificación Bacteriana , Brasil , Infección Hospitalaria/microbiología , Pruebas Antimicrobianas de Difusión por Disco , ADN Bacteriano/análisis , Fenotipo , Reacción en Cadena de la Polimerasa/métodos
19.
Artículo en Inglés | IMSEAR | ID: sea-157343

RESUMEN

Background and Objectives: Sepsis remains a clinical challenge in the Indian intensive care nurseries. Neonatal sepsis due to Acinetobacter species has been reported in recent years. Because of their multidrug resistance pattern, Acinetobacters pose a challenge regarding management of patients. The present study was therefore undertaken to find out the prevalence of Acinetobacter species in cases of neonatal septicemia and also to find out the antimicrobial susceptibility pattern of all Acinetobacter isolates. Methods: Eighty Acinetobacter isolates from blood culture samples from neonates with signs and symptoms of septicemia were speciated by standard biochemical tests and their antimicrobial susceptibility testing was done by Kirby Bauer Disk Diffusion (KBDD) method according to CLSI guidelines. Results: Incidence of neonatal septicemia due to Acinetobacter species was 9.18% out of total blood culture positive samples and predominant species was Acinetobacter baumanii (67.5%), followed by Acinetobacter junii (20%). Acinetobacter species showed maximum susceptibility to netilmicin (86.25%), followed by imipenem (70%). Acinetobacter junii showed greater susceptibility than Acinetobacter baumanii. Conclusion: This study indicates that neonatal sepsis due to Acinetobacter species is on the rise. Acinetobacter baumanii is multiresistant type and has direct bearing on mortality, so it highlights the importance of formulating a proper antibiotic policy in every hospital in cases of neonatal sepsis. The differences in resistant patterns among isolates emphasizes the need for differentiating A. baumanii from other Acinetobacter species by special biochemical tests.


Asunto(s)
Acinetobacter/efectos de los fármacos , Acinetobacter/aislamiento & purificación , Acinetobacter/microbiología , Humanos , India , Recién Nacido , Cuidado Intensivo Neonatal , Pruebas de Sensibilidad Microbiana , Sepsis/sangre , Sepsis/etiología , Sepsis/microbiología
20.
Rev. argent. microbiol ; 43(2): 115-119, jun. 2011. ilus, graf, tab
Artículo en Español | LILACS | ID: lil-634682

RESUMEN

El objetivo de este estudio fue evaluar comparativamente los métodos de predifusión y de concentración inhibitoria mínima para establecer la sensibilidad de aislamientos del complejo Acinetobacter calcoaceticus-baumannii (ABC) a la colistina y detectar a aquellos que presenten heterorresistencia a dicho antibiótico. Se estudiaron 75 aislamientos de ABC recuperados de materiales clínicamente significativos. Se determinó su sensibilidad a la colistina por el método de predifusión y de concentración inhibitoria mínima. Todos los aislamientos resultaron sensibles, con CIM = 2 µg/ml y halos de inhibición en el ensayo de la predifusión = 20 mm. Mediante el método de eficiencia de plaqueo se evaluó la presencia de heterorresistencia a la colistina. Se encontraron 14 aislamientos que originaron colonias heterorresistentes; sus CIM aumentaron en algunos casos en más de 8 veces. Con estas colonias seleccionadas se repitió el ensayo de predifusión. Finalmente se confeccionaron los gráficos de dispersión y se realizaron los análisis de regresión lineal, tanto para el conjunto inicial de todos los aislamientos clínicos como para el subgrupo de los aislamientos resistentes generados durante la evaluación de la heterorresistencia. Se obtuvieron coeficientes de determinación (r²) de 0,2017 y 0,604, respectivamente, lo que indica correlación entre los métodos sólo al evaluar aislamientos preseleccionados por su resistencia a este agente.


The objective of this study is to perform a comparative evaluation of the prediffusion and minimum inhibitory concentration (MIC) methods for the detection of sensitivity to colistin, and to detect Acinetobacter baumanii-calcoaceticus complex (ABC) heteroresistant isolates to colistin. We studied 75 isolates of ABC recovered from clinically significant samples obtained from various centers. Sensitivity to colistin was determined by prediffusion as well as by MIC. All the isolates were sensitive to colistin, with MIC = 2µg/ml. The results were analyzed by dispersion graph and linear regression analysis, revealing that the prediffusion method did not correlate with the MIC values for isolates sensitive to colistin (r² = 0.2017). Detection of heteroresistance to colistin was determined by plaque efficiency of all the isolates with the same initial MICs of 2, 1, and 0.5 µg/ml, which resulted in 14 of them with a greater than 8-fold increase in the MIC in some cases. When the sensitivity of these resistant colonies was determined by prediffusion, the resulting dispersion graph and linear regression analysis yielded an r² = 0.604, which revealed a correlation between the methodologies used.


Asunto(s)
Humanos , Acinetobacter/efectos de los fármacos , Colistina/farmacología , Farmacorresistencia Microbiana , Pruebas de Sensibilidad Microbiana/métodos , Argentina , Infecciones por Acinetobacter/microbiología , Acinetobacter baumannii/efectos de los fármacos , Acinetobacter baumannii/aislamiento & purificación , Acinetobacter calcoaceticus/efectos de los fármacos , Acinetobacter calcoaceticus/aislamiento & purificación , Acinetobacter/aislamiento & purificación , Difusión , Pruebas Antimicrobianas de Difusión por Disco , Farmacorresistencia Bacteriana Múltiple , Modelos Lineales
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA